Home / Resource Library / Anti-CD30 CAR T-cell therapy in patients with heavily pretreated R/R HLAnti-CD30 CAR T-cell therapy in patients with heavily pretreated R/R HL Results of a study examining CD30 CAR T therapy for the treatment of relapsed Hodgkin lymphoma.